Mometamax Ultra RSS Authorised This medicine is authorised for use in the European Union gentamicin / posaconazole / mometasone furoate Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Mometamax Ultra Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Mometamax Ultra Active substance gentamicinMometasone furoateposaconazole International non-proprietary name (INN) or common name gentamicinposaconazolemometasone furoate Pharmacotherapeutic groupOtologicalsCorticosteroidsAntiinfectives Authorisation details EMA product number EMEA/V/C/004987 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for Mometamax UltraAdopted Reference Number: EMA/CVMP/793345/2022 English (EN) (136.12 KB - PDF)First published: 07/10/2022 View News on Mometamax Ultra Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 October 202510/10/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 June 202513/06/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 October 202411/10/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 202207/10/2022 This page was last updated on 08/02/2024 Share this page